3rd Quarter - Report

MEHLMAN CONSULTING, INC. for AEGIS SCIENCES CORPORATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare contractor issues related to coverage and reimbursement for drugs, including accreditation issues. Clinical Laboratory Fee Schedule and Physician Fee Schedule Proposed Medicare Rules. S. 2761/H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (The RESULTS Act).

LobbyistCovered position, as disclosed
JON ADAME —
LAUREN ARONSON —
SEAN BRADY New Dir Leg Affairs (DOC, Intl Trade Admin); CoS, Dep. CoS/ LD, SLA, LA, Staff Asst (Rep. Vern Buchanan); Intern (Rep. Fred Upton); Intern (Rep. Dan Lungren)
JOSEPH EDWARD BROWN —
ERICA JAY CHABOT —
STEPHEN M. COTE —
NICHOLE DISTEFANO —
SAGE EASTMAN —
ELISE FINLEY PICKERING —
EARL SCOTT FLOOD —
LISA GOLDMAN —
ROSEMARY GUTIERREZ —
ZACHARY MALLOVE —
BRUCE MEHLMAN —
ALYENE MLINAR —
NAVEEN PARMAR —
ALEXANDER PERKINS —
MICHAEL ROBINSON —
DEAN ROSEN —
DAVID R THOMAS —
PAUL THORNELL —
HELEN TOLAR —
CAITLIN VAN SANT —
ANNIE WOLF —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); SENATE

Bills named: H.R. 5269 (119th), S. 2761 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.